CD276 and bladder transitional cell carcinoma: In this study, we thoroughly examined CD276 expression to investigate its association with the prognosis and immune infiltration in BLCA, providing novel insights into potential diagnostic and therapeutic strategies for bladder urothelial carcinoma.